GE Aerospace vs Zoetis Inc — how do they compare? GE Aerospace trades at $340.53 (market cap $375.97B), while Zoetis Inc trades at $77.15 (market cap $31.25B). The key difference: GE Aerospace is far larger — about 12× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.84%). Which is the better fit depends on your goals.
| GE | ZTS | |
|---|---|---|
Market Cap | $375.97B | $31.25B |
Sector | Industrials | Health |
52-Week High | $378.68 | $156.76 |
52-Week Low | $259.00 | $71.91 |
Enterprise Value | $385.26B | $38.54B |
Dividend Yield | 0.52% | 2.84% |
Signals from Pluang's Aura AI — not financial advice
GE trades at $353.73, up 0.09% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q1 2026 EPS of $1.86 versus $1.60 expected, driven by robust aerospace demand and defense contract wins. Revenue grew to $45.86 billion in 2025, with net income margin improving to 18.98%. Analysts maintain a strong buy consensus with a $402.63 price target, reflecting optimism about order growth and backlog strength.
Outlook remains positive given earnings momentum and strategic investments in MRO and propulsion, though high valuation ratios (P/E 43.94) and debt levels pose risks. The stock offers upside to consensus targets but faces pressure from rising costs and competitive dynamics in aerospace and defense sectors.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →